Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-833-9 | CAS number: 5107-67-5
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Date of administration: July 4, 1990 and July 12, 1990 ; Date of completion: July 26, 1990.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- other: Limit test.
- Limit test:
- yes
Test material
- Reference substance name:
- 2-oxocyclohexane-1,1,3,3-tetrapropionic acid
- EC Number:
- 225-833-9
- EC Name:
- 2-oxocyclohexane-1,1,3,3-tetrapropionic acid
- Cas Number:
- 5107-67-5
- Molecular formula:
- C18H26O9
- IUPAC Name:
- 3-[1,3,3-tris(2-carboxyethyl)-2-oxocyclohexyl]propanoic acid
- Test material form:
- not specified
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Albino rats Tif: RAI f (SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Choice of species: The rat has been selected for this test as being a standard species for the determination of the acute oral toxicity.
Young adult albino rats of both sexes (Tif: RAI f (SPF)), initial age 6 to 8 weeks, bred and raised on the premises, were used in the experiment.
- Source: CIBA-GEIGY Limited, Animal Production, 4332 Stein/Switzerland
- Initial body weight range: 171 to 218 grams.
Hunsbandry and diet:
The rats were kept in an animal room under conventional laboratory conditions, on a 12 hour/day light cycle. The air conditioning system (approximately 15 air changes per hour) maintened a temperature of 22 +/-2°C and relative humidity of 55 +/- 10%.
The animals were housed in Macrlon cages type 4, with standardized soft wood beddling (Societe Parisienne des Sciures, Pantin, France). They were acclimatized at least for 5 days before administration. Rat diet (NAFAG 890 Tox, NAFAG Gossau/SG, Switzerland) and waterwere provided ad libitum. Prior to dosing, the animals were fasted overnight.
Group size and identification:
The animals, segregated by sex, were group-housed (5 animals per cage). Within the groups the animals were identified with numbers from 1 to 5 using picric acid stain on the fur. After dosing, the animals were placed in their cages, which were marked with a cage card containing the date of administration and the characteristics of the experiment and dose group.
Administration / exposure
- Route of administration:
- other: Gastric intubation (GAVAGE), one single oral dose.
- Vehicle:
- other: 0.5 % (w/v) carboxymethylcellulose in 0.1% (w/v) aqueous polysorbate 80 (Prepared by Pharmaceuticals Division, Ciba-Geigy Ltd.,Basel)
- Details on oral exposure:
- - VEHICLE: 0.5 % (w/v) carboxymethylcellulose in 0.1% (w/v) aqueous polysorbate 80 (Prepared by Pharmaceuticals Division, Ciba-Geigy Ltd.,Basel).
- DOSE VOLUME APPLIED: 10 ml/kg body weight - Doses:
- 2000 mg/kg (males and females)
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes. The animals were submitted to a gross necropsy at the ned of the observation period.
- Other examinations performed: clinical signs, body weight, rate of death, necropsy.
Observations and records:
- Mortality: Daily; a.m. and p.m. on working days, a.m. on weekend days.
- Signs and symptoms: Daily for 14 days.
- Body weight: Immediately before administration and on days 7 and 14. - Statistics:
- From the body weights, the group means and their standard deviations were calculated.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occured in the study.
- Clinical signs:
- other: Piloerection, hunched posture and dyspnea were seen, being common symptoms in acute tests. Additionally, reduced locomotor activity was observed in one female one hour after administration. The animals recovered within 4 to 6 days.
- Gross pathology:
- At autopsy, no deviations from normal morphology were found.
Any other information on results incl. tables
Mean body weight and standard deviation (g).
| Administration day | Day 7 | Day 14 | |
| Males 2000 mg/kg | 209 +/- 7.6 | 265 +/- 10.7 | 299 +/- 8.8 |
| Females 2000 mg/kg | 181 +/- 10.3 | 209 +/- 8.9 | 235 +/- 17.8 |
Observation of symptoms.
| hrs after adm. | Days after administration | |||||||||||
| Observations | 1 | 3 | 5 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 -14 |
| 2000 mg/kg, males | ||||||||||||
| piloerection | + | ++ | ++ | + | + | + | ||||||
| hunched post | + | + | + | + | ||||||||
| dyspnea | + | + | + | |||||||||
| 2000 mg/kg, females | ||||||||||||
| piloerection | ++ | ++ | ++ | + | + | + | + | + | ||||
| hunched post. | + | + | + | + | + | + | + | |||||
| dyspnea | + | + | + | + | + | + | ||||||
| red. loc. act. | + | |||||||||||
+ = slight
++ = moderate
+++ = severe
hunched post=hunched posture
red.loc.act. = reduced locomotor activity
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- LD50 in male rats: greater than 2000 mg/kg body weight.
LD50 in female rats: greater than 2000 mg/kg body weight.
LD50 in rats of both sexes: greater than 2000 mg/kg body weight. - Executive summary:
The study was conducted to determine the acute oral toxicity of test item in albinos rats.
The study design followed the OECD Guideline 401, "Acute Oral Toxicity", adopted February 24, 1987 and the study protocol from June 18, 1990.
Upon an acute oral administration and a 14 day post-treatment observation period, the following LD50 (with 95% confidence limits calculated, where possible) was determined for the test substance.
- LD50 in male rats: greater than 2000 mg/kg body weight.
- LD50 in female rats: greater than 2000 mg/kg body weight.
- LD50 in rats of both sexes: greater than 2000 mg/kg body weight.
Observations:
Piloerection, hunched posture and dyspnea were seen, being common symptoms in acute test. Additionally, reduced locomotor activity was observed in one female one hour after administration.
The animals recovered within 4 to 6 days.
At autopsy, no deviations from normal morphology were found.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
